Coding and reimbursement of primary care biopsy and destruction procedures.
Current medical practice requires physicians to accurately report services provided to patients. Billing for destruction of benign and malignant lesions and for surgical, needle, and endoscopic biopsy procedures involves the selection of specific 1992 Current Procedural Terminology (CPT) codes. Payment for these procedures by third-party payers often requires the International Classification of Diseases, 9th Revision, Clinical Modification (ICD-9-CM) coding for neoplastic lesions. This review explains the proper codes to use in identifying common biopsy and destruction procedures performed by primary care physicians. The Health Care Financing Administration's relative value units and one state's published Medicaid payment rates are included for each procedure code. Instructions for selecting site-specific biopsy and destruction codes are provided.
Zuber
T J
TJ
Department of Family Medicine, East Carolina University School of Medicine, Greenville, NC 27858-4354.
Purvis
J R
JR
D000043:Abstracting and Indexing; D001706:Biopsy / Q000145:classification / Q000191:economics*; D001707:Biopsy, Needle / Q000145:classification / Q000191:economics / Q000379:methods; D004724:Endoscopy / Q000145:classification; D006801:Humans; D007344:Insurance Claim Reporting / Q000145:classification*; D007349:Insurance, Health, Reimbursement / Q000145:classification*; D008484:Medicaid / Q000191:economics; D006278:Medicare / Q000191:economics; D009369:Neoplasms / Q000191:economics / Q000601:surgery; D009657:North Carolina; D011320:Primary Health Care / Q000145:classification / Q000191:economics; D013514:Surgical Procedures, Operative / Q000145:classification / Q000191:economics*; D014481:United States